) BioElectronics Corporation's ActiPatch®, The New Technology for Pain Relief medical device, has won the Orthopedics This Week Sports Medicine Technology Award. Orthopedics This Week is the most ...

Successful implantation and treatment underway in world’s first patient receiving experimental therapy for Rheumatoid Arthritis (RA) using splenic nerve stimulation Electrical stimulation of nerves ...

Newswise — BOSTON —January 10, 2017— Micro-Leads Inc. is among three recipients around the world awarded $1 million to develop an advanced bioelectronics medicine device for GlaxoSmithKline’s (GSK) ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in bioelectronic devices. In 1999, I defined regenerative medicine as the collection ...

Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away. That's the vision of the field of bioelectronic ...

GlaxoSmithKline (GSK) announced that it is partnering with Verily Life Sciences LLC to form Galvani Bioelectronics. According to the press release, GSK and Verily will contribute IP rights and an ...

For diseases and health conditions related to nerves, highly specific electronic impulses could do more healing than any pharmaceutical drug. Scientists and doctors have long harnessed the power of ...

Neural prostheses or neural stimulators are implantable devices that use electrical stimulation of neural tissue to provide therapeutic intervention, sensory feedback or improved motor control ...

REDONDO BEACH, CA--(Marketwired - Oct 18, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public filing alerts, recently published a report on the ...

Bioelectronics combines biology and electronics to sense, stimulate, modulate, or communicate with living systems. It includes neural interfaces, implantable devices, wearable sensors, electronic skin ...

SAN FRANCISCO--(BUSINESS WIRE)--Galvani Bioelectronics, a clinical-stage company formed through a strategic partnership between GlaxoSmithKline (GSK) and Verily Life Sciences (Verily) in 2016 with the ...